SAM Medical · Junctional Tourniquet SAM® Junctional Tourniquet An FDA-cleared pneumatic junctional tourniquet for hemorrhage at the trunk–appendage junction — inguinal and axillary sites a circumferential limb tourniquet cannot reach — and for pelvic fracture stabilisation. Pneumatic Target Compression Devices are placed over the artery and inflated by hand pump; an AUTOSTOP buckle caps belt tension at 150 N. NSN 6515-01-618-7475. Pneumatic TCDAUTOSTOP buckle · 150 NNSN 6515-01-618-7475510(k) cleared 2013 CoTCCC removed the recommended designation from junctional tourniquets entirely in 2021 — no product in this category carries it, so device selection is a medical-director decision made on evidence, training burden and sustainment. What's Included SAM Medical publishes two pack configurations under this product — JT400-EN and JT401-EN — and they do not ship the same components. This listing carries a single variant and does not state which configuration is supplied. Both are itemised below; confirm the configuration before ordering. VIEW ▾JT400-EN — two-TCD configuration — as published by SAM Medical 1× SAM® Junctional Tourniquet belt with AUTOSTOP Buckle — limits circumferential belt tension to 150 N 2× Target Compression Device (TCD) — repositionable, removable pneumatic compression pad; two TCDs allow simultaneous bilateral inguinal application 1× Belt extender 1× Hand pump 1× Auxiliary strap The legacy listing itemises this configuration as '2 TCD + extender + pump + aux strap'. It does not state whether an instructions-for-use card is packed; confirm with SAM Medical. VIEW ▾JT401-EN — single-TCD configuration — as published by SAM Medical 1× SAM® Junctional Tourniquet belt with AUTOSTOP Buckle — limits circumferential belt tension to 150 N 1× Target Compression Device (TCD) — repositionable, removable pneumatic compression pad 1× Hand pump No belt extender and no auxiliary strap are listed for this configuration. Bilateral inguinal application requires two TCDs and is therefore not supported by this pack as itemised. The legacy listing itemises this configuration as '1 TCD + pump' and does not state whether an instructions-for-use card is packed. ▾Specifications SAM® Junctional Tourniquet — specifications Specification Detail Manufacturer SAM Medical (Wilsonville, OR) SKUs JT400-EN — 2 TCD + extender + pump + auxiliary strap · JT401-EN — 1 TCD + pump NSN 6515-01-618-7475 Mechanism Pneumatic — hand-pump-inflated Target Compression Device (TCD) with AUTOSTOP Buckle Belt tension limit AUTOSTOP Buckle caps circumferential tension at 150 N, per SAM Medical Inflation time SAM Medical states the TCDs inflate in under 25 seconds by hand pump Indications SAM Medical states inguinal hemorrhage, axillary hemorrhage and pelvic fracture stabilisation Maximum application time SAM Medical states 4 hours (inguinal / axillary), with clinical monitoring per local protocol. The legacy listing does not cite the source document — verify against the current SAM Medical instructions for use before relying on this figure. Platform origin Developed from the SAM® Pelvic Sling platform Weight Approx. 2 lb, packaged configuration Packaged dimensions 12″ H × 7.5″ W × 4.5″ D FDA clearance 510(k) cleared 18 March 2013 Country of origin Made in the USA CoTCCC status Not CoTCCC-recommended, and no junctional tourniquet is. TCCC Guidelines direct the use of a junctional tourniquet where the bleeding site is amenable to one, but in its 2021 update CoTCCC removed the recommended designation from the junctional-tourniquet category entirely and directs end users to select any FDA-cleared device indicated for junctional hemorrhage control. Preclinical evidence A cadaveric study (Johnson et al., Journal of Special Operations Medicine, 2014) reported occlusion of the distal external iliac artery at a mean 107 mmHg versus 139 mmHg for manual compression, and 739 mmHg versus 1,237 mmHg at the axilla. A manikin comparison (Kragh et al., Prehospital and Disaster Medicine, 2016) reported the least blood loss of four tested junctional devices in groin scenarios. Both are preclinical models — read them as mechanism and usability evidence, not as a demonstrated survival benefit. Fielding history The U.S. Army Medical Materiel Agency fielded 460 units to theatre in October 2013 following FDA clearance. Junctional hemorrhage — compressible bleeding at the groin, pelvis and axilla — is described in the Joint Trauma System literature as the largest remaining category of potentially survivable compressible hemorrhage after limb tourniquets were widely fielded. The common femoral artery exits the pelvis immediately below the inguinal ligament, too proximal for a limb-tourniquet cuff to engage. ▾Who Carries It Combat medics, SOF medical providers and CASEVAC teams operating where blast mechanisms produce bilateral high-thigh wounds and proximal amputations · Tactical EMS and law-enforcement medics carrying a junctional capability alongside limb tourniquets · Role 1/2 and prolonged-field-care elements managing pelvic fracture as well as junctional bleeding · Trauma programmes and training centres standing up a junctional-hemorrhage capability. A junctional tourniquet is a trained-provider device: placement over the correct arterial landmark, inflation to the endpoint, monitoring during the application window and the decision to convert or remove all sit under training and medical-director protocol. Application technique and time limits belong to the manufacturer's instructions for use and your local protocol — not to a product page. Genuine SAM Medical Sourced direct from the manufacturer or an authorized master distributor. Ships from MED-TAC International, Pembroke Pines, FL — clinician-founded, veteran-led, SDVOSB-certified.
